TRVI Dividend History & Analysis | N/A Yield
TRVI has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| SIGA | 480 M | 10.4% | 12.2% |
| GS71 | 118,497 M | 4.22% | 7.28% |
| BMY | 113,778 M | 4.98% | 5.04% |
| SAN | 113,221 M | 4.30% | 5.91% |
| SNY | 114,158 M | 4.43% | 5.55% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| ZTS | 54,250 M | 18.9% | 100% |
| VIRP | 3,475 M | 17.9% | 82.1% |
| LLY | 915,139 M | 15.3% | 99.5% |
| BMY | 113,778 M | 14.0% | 92.6% |
| MRK | 64,417 M | 12.0% | 91.8% |
Quality Dividend Peers in Pharmaceuticals
4.98% Yield
3.70% Yield
3.02% Yield
3.68% Yield
1.34% Yield
2.08% Yield
TRVI Dividend History: as of February 2026
No dividends paid yet.TRVI Dividend FAQ
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is a clinical-stage biopharma focused on oral nalbuphine-based products for chronic cough associated with idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases, as well as refractory cough and pruritus conditions. Its lead candidate, Haduvio (extended-release nalbuphine), is currently in a Phase 2b trial for cough reduction in IPF patients, a Phase 2 trial for pruritus, and a combined Phase 2b/3 study for prurigo nodularis. The company operates under a license with Endo Pharmaceuticals to develop and commercialize nalbuphine formulations.
What is the Dividend Yield of TRVI?
As of February 2026, TRVI`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 11.46.Does TRVI pay a dividend?
As of February 2026 TRVI does not pay a dividend.How often does TRVI pay dividends?
Over the last 12 months, TRVI has issued dividend payments.TRVI dividend forecast
Based on historical data, the forecasted dividends per share for TRVI for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will TRVI pay dividends in 2026?
The next Ex-Dividend date for Trevi Therapeutics (TRVI) is currently unknown.What is the next Ex-Dividend Date for TRVI?
The next Ex-Dividend date for Trevi Therapeutics (TRVI) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of TRVI?
TRVI's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of TRVI?
TRVI's 5-Year Yield on Cost is -%. If you bought TRVI's shares at 3.55 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of TRVI?
TRVI Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does TRVI have a good Dividend Yield?
TRVI`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of TRVI?
The Dividend Payout Ratio of TRVI is unknown.What is the Dividend Rating of TRVI?
TRVI`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-02-02 02:15